Profund Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$937K Sell
29,526
-12,928
-30% -$352K 0.03% 363
2025
Q4
$1.15M Buy
42,454
+21,149
+99% +$557K 0.04% 320
2025
Q3
$551K Buy
21,305
+5,880
+38% +$136K 0.02% 482
2025
Q2
$314K Sell
15,425
-7,220
-32% -$141K 0.01% 665
2025
Q1
$411K Sell
22,645
-6,789
-23% -$152K 0.02% 544
2024
Q4
$744K Buy
29,434
+10,873
+59% +$295K 0.03% 362
2024
Q3
$631K Sell
18,561
-3,945
-18% -$150K 0.02% 444
2024
Q2
$833K Sell
22,506
-7,841
-26% -$296K 0.03% 351
2024
Q1
$1.27M Buy
30,347
+5,861
+24% +$241K 0.05% 296
2023
Q4
$971K Sell
24,486
-3,553
-13% -$105K 0.04% 331
2023
Q3
$772K Sell
28,039
-9,382
-25% -$294K 0.04% 345
2023
Q2
$1.27M Buy
37,421
+10,049
+37% +$339K 0.07% 263
2023
Q1
$985K Buy
+27,372
New +$1.18M 0.06% 305

Other funds holding CLDX